Secondary y amyloidosis (AA) and renal disease;Amiloidosis secundaria (AA) y afectación renal

Nefrologia

Volumn 23, Issue 4, 2003, Pages 321-326

  Torregrosa, E ^a   Hernandez Jaras J ^a   Calvo, C ^a   Rius A ^a   Garcia Perez H ^a   Maduell, F ^a   Vera, J M ^a  

^a HOSPITAL GENERAL DE CASTELLÓN   (Spain)

Author keywords

AA amyloidosis; Renal failure

Indexed keywords

CREATININE; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT; SERUM AMYLOID A;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; BLEEDING; CACHEXIA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIALYSIS; FEMALE; HEMATURIA; HUMAN; INFECTION; KIDNEY DISEASE; MALE; PROTEINURIA; RHEUMATIC DISEASE; SURVIVAL RATE; COMPARATIVE STUDY; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED;

AMYLOIDOSIS; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROTEINURIA; SERUM AMYLOID A PROTEIN;

EID: 0642308205     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Friman C, Petterson T: Amyloidosis. Current Opinion in Rheumatology 8: 63-71, 1996.
2. Glenner GG: Amyloid deposit and amyloidosis. The beta-fibrilloses. The New England Journal of Medicine 302 (23): 1283-92, 1980.
3. Hazenberg B, Van Rijwisk M: Clinical and therapeutic aspects of AA amyloidosis. Clinical Rheumatology 8 (3): 661-690, 1994.
4. Gertz MA, Kyle RA: Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 70 (4): 246-256, 1991.
5. Joss N, McLaughlin K, Simpson K, Boulton-Jones JM: Presentation, survival and prognosis markers in AA amyloidosis. Q J Med 93: 535-542, 2000.
6. Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakioglu S, Ataman R, Akpolat T, Ok E, Sen S, Düsünsel R, Evrenkaya R, Akoglu E: A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant 17: 2003-2005, 2002.
7. Hiki Y, Harii A, Kokubo T: A case of rheumatoid arthritis with renal tubular amyloid. Nephron 68: 394, 1994.
8. Westermark G, Sletten K, Westermark P: Massive vascular AA-amyloidosis: a histologically and biochemically subtype of reactive sistemic amyloidosis. Scand J Immunol 30 (5): 605-613, 1989.
9. Rivera F, Gil CM, Gil MT, Batlle-Gualda, Trigueros M, Olivares J: Vascular renal AA amyloidosis in adult Still's disease. Nephrol Dial Transplant 12: 1714-1716, 1997.
10. Bronsoms JM, Vallés M, Has H, Sant F, Llobet M: Pielonefritis xantogranulomatosa y amiloidosis sistémica. Nefrología Vol. XV: 371-374, 1995.
11. Almirall J, López T, Saez A, Gracatós J, Prats J: Amiloidosis sistémica secundaria a pielonefritis xantogranulomatosa. Nefrología Vol. XXI (5): 505-508, 2001.
12. Rivera F, Egea J, Gil C, Trigueros M, Olivares J: Systemic amyloidosis secondary to xantogranulomatous pyelonephritis. Nephrol Dial Transplant 13: 2416-2417, 1998.
13. Paydas S: Report on 59 patients with renal amyloidosis. Int Urol Nephrology 31 (5): 619-31, 1999.
14. Chevrel G, Jenvrin C, McGregor B, Miossec P: Renal type AA amyloidosis with rheumatoide arthritis: a cohor study showin improved survival on treatment with pulse cyclophosphamide. Rheumatology 40 (7): 821-825, 2001.
15. Uhlar CM, Whitehead AS: Serum amyloid A, the major vertebrate acute-reactant. Eur J Biochem 265: 501-523, 1999.
16. Odabas AR, Cetinkaya R, Selcuk Y, Erman Z, Bilen H: Clinical and biochemical outcome of renal amyloidosis. Int J Clin Pract 56 (5): 342-344, 2002.
17. Kuroda T, Tanabe N, Sakatsume M, Nozawa S, Mitsuka T, Ishikawa H, Tohyama CT, Nakazono K, Murasawa A, Nakano M, Gejyo F: Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amiloidosis in rheumatoid arthritis. Clin Rheumatol 21: 123-128, 2002.
18. Gillmore JD, Lovat LV, Persey MR, Pepys MB, Hawkins PN: Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358: 24-29, 2001.
19. David J, Voujiouka O, Ansell BM, Hall A, Woop P: Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. Clin Exp Rheumatol 11: 85-90, 1993.
20. Bakalrishnan C, Sule A, Mittal G, Gaitonde S, Pathan E, Rajadhyaksha S, Despande RB, Gurmeet M, Samant R, Joshi VR: Treatment of AA amyloidosis in rheumatoid arthritis. J Assoc Physicians India 50: 907-909, 2002.
21. Livned A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M: Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthri Rheum 37: 1804-1811, 1994.
22. Moroni G, Banfi G, Montoli A, Bucci A, Bertani T, Ravelli M, Pozzi C, Leonelli M, Lupo A, Volpi A: chronic dialysis in patients with systemic amyloidosis: the experience in northern Italy. Clin Nephrol 38: 81-85, 1992.
23. Ylinen K, Gronhagen-Riska C, Honkanen E, Ekstrand A, Metsarinne K, Kuhlback B: Outcome of patients with secondary amyloidosis in dialysis treatment. Nephrol Dial Transplant 7: 908-912, 1992.
24. Generalitat Valenciana: Consellería de Sanitat. Registro de Enfermos Renales de la Comunidad Valenciana Informe 1999. Series Informe de Salud núm. 64. Valencia 2000.